1 – 86 of 86
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Health-related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study)
(
- Contribution to journal › Article
- 2023
-
Mark
Management of influenza–updated Swedish guidelines for antiviral treatment
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia : a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study
(
- Contribution to journal › Article
-
Mark
Considerations for shared decision management in previously untreated patients with hemophilia A or B
(
- Contribution to journal › Scientific review
-
Mark
Exposure to Biological Fluids in Dental Practice—Narrative Review on Appropriate Risk Assessment to Guide Post-Exposure Management
(
- Contribution to journal › Scientific review
- 2022
-
Mark
New Inhibitors in the Ageing Population : A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia
(
- Contribution to journal › Article
-
Mark
Clinical studies of extended-half-life recombinant FVIII products for prophylaxis in adults and children : A critical review from the physician's perspective
(
- Contribution to journal › Scientific review
-
Mark
Quality of life in a large multinational haemophilia B cohort (The B-Natural study) – Unmet needs remain
(
- Contribution to journal › Article
-
Mark
Immune tolerance induction in the era of emicizumab – still the first choice for patients with haemophilia A and inhibitors?
(
- Contribution to journal › Article
- 2021
-
Mark
Translating the success of prophylaxis in haemophilia to von Willebrand disease
(
- Contribution to journal › Scientific review
-
Mark
Comparison of single subject and population-based pharmacokinetics for optimizing prophylaxis with simoctocog alfa in patients with haemophilia A
(
- Contribution to journal › Article
-
Mark
Thromboembolism in Muscle-Invasive Bladder Cancer. A Population-based Nationwide Study
(
- Contribution to journal › Article
-
Mark
Haemophilia early arthropathy detection with ultrasound and haemophilia joint health score in the moderate haemophilia (MoHem) study
(
- Contribution to journal › Article
-
Mark
Optimising prophylaxis in haemophilia A : The ups and downs of treatment
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Achieving the unimaginable : Health equity in haemophilia
(
- Contribution to journal › Scientific review
-
Mark
Joint health and treatment modalities in Nordic patients with moderate haemophilia A and B – The MoHem study
(
- Contribution to journal › Article
- 2019
-
Mark
Factor VIII : Long-established role in haemophilia A and emerging evidence beyond haemostasis
(
- Contribution to journal › Scientific review
-
Mark
Noninvasive fetal RHD genotyping to guide targeted anti-D prophylaxis–an external quality assessment workshop
(
- Contribution to journal › Article
- 2018
-
Mark
Haemophilia B : Where are we now and what does the future hold?
(
- Contribution to journal › Scientific review
-
Mark
Social and economic burden of recurrent urinary tract infections and quality of life : a patient web-based study (GESPRIT)
(
- Contribution to journal › Article
-
Mark
Bleeding-related hospitalization in patients with von Willebrand disease and the impact of prophylaxis : Results from national registers in Sweden compared with normal controls and participants in the von Willebrand Disease Prophylaxis Network
(
- Contribution to journal › Article
-
Mark
Defining extended half-life rFVIII-A critical review of the evidence
(
- Contribution to journal › Article
- 2017
-
Mark
Effect of late prophylaxis in hemophilia on joint status : A randomized trial
(
- Contribution to journal › Article
-
Mark
Higher risk of revision for infection using systemic clindamycin prophylaxis than with cloxacillin : A report from the Swedish Knee Arthroplasty Register on 78,000 primary total knee arthroplasties for osteoarthritis
(
- Contribution to journal › Article
-
Mark
Primary prophylaxis in haemophilia care : Guideline update 2016
(
- Contribution to journal › Article
- 2016
-
Mark
Prophylaxis for Hemophilia in the Era of Extended Half-Life Factor VIII/Factor IX Products
(
- Contribution to journal › Article
-
Mark
Haemophilia treatment in 2030
(
- Contribution to journal › Article
-
Mark
Aspects of prophylactic treatment of hemophilia
(
- Contribution to journal › Scientific review
-
Mark
Does the intensity and quality of treatment and not only the factor VIII level influence global hemostasis in patients with hemophilia A?
(
- Contribution to journal › Letter
- 2015
-
Mark
Controlled, cross-sectional MRI evaluation of joint status in severe haemophilia A patients treated with prophylaxis vs. on demand
(
- Contribution to journal › Article
-
Mark
Various regimens for prophylactic treatment of patients with haemophilia
(
- Contribution to journal › Scientific review
-
Mark
Strategies for reducing inhibitor formation in severe haemophilia
(
- Contribution to journal › Scientific review
-
Mark
How to achieve full prophylaxis in young boys with severe haemophilia A: different regimens and their effect on early bleeding and venous access
(
- Contribution to journal › Article
-
Mark
Post-operative nausea and vomiting : Update on predicting the probability and ways to minimize its occurrence, with focus on ambulatory surgery
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Real-time PCR-assay in the delivery suite for determination of group B streptococcal colonization in a setting with risk-based antibiotic prophylaxis
(
- Contribution to journal › Article
-
Mark
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2013
(
- Contribution to journal › Scientific review
-
Mark
On-demand treatment in persons with severe haemophilia
(
- Contribution to journal › Scientific review
-
Mark
Methods for individualising factor VIII dosing in prophylaxis
(
- Contribution to journal › Scientific review
-
Mark
Prospective observational cohort studies for studying rare diseases: the European PedNet Haemophilia Registry
(
- Contribution to journal › Article
-
Mark
Factor VIII therapy for hemophilia A: current and future issues
(
- Contribution to journal › Scientific review
-
Mark
Evaluating national guidelines for the prophylactic treatment of respiratory syncytial virus in children with congenital heart disease
(
- Contribution to journal › Article
- 2013
-
Mark
Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study
(
- Contribution to journal › Article
-
Mark
Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN)
(
- Contribution to journal › Article
-
Mark
Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study
(
- Contribution to journal › Article
- 2011
-
Mark
Bone Mineral Density in Haemophilila: A Treatment Outcome
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Joint protection in haemophilia
(
- Contribution to journal › Article
-
Mark
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations 2010
(
- Contribution to journal › Scientific review
-
Mark
Intracranial bleeding due to vitamin K deficiency : Advantages of using a pediatric intensive care registry
(
- Contribution to journal › Article
- 2010
-
Mark
FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations
(
- Contribution to journal › Article
-
Mark
Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa)
(
- Contribution to journal › Article
-
Mark
Devising a best practice approach to prophylaxis in boys with severe haemophilia: evaluation of current treatment strategies
(
- Contribution to journal › Scientific review
-
Mark
The role of prophylaxis in bleeding disorders
(
- Contribution to journal › Scientific review
-
Mark
Hydrolysed formula is a risk factor for vitamin K deficiency in infants with unrecognised cholestasis
(
- Contribution to journal › Article
- 2009
-
Mark
Treatment and prevention of acute bleedings in von Willebrand disease--efficacy and safety of Wilate, a new generation von Willebrand factor/factor VIII concentrate.
(
- Contribution to journal › Article
-
Mark
Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A
(
- Contribution to journal › Article
-
Mark
Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs
(
- Contribution to journal › Scientific review
- 2008
-
Mark
Prevention of arthropathy: may it be extrapolated from patients without inhibitors to patients with inhibitors?
(
- Contribution to journal › Article
-
Mark
Prevention of haemophilic arthropathy during childhood. May common orthopaedic management be extrapolated from patients without inhibitors to patients with inhibitors?
(
- Contribution to journal › Article
-
Mark
Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors
(
- Contribution to journal › Article
-
Mark
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
(
- Contribution to journal › Article
-
Mark
Prevention of vitamin k deficiency bleeding in breastfed infants : lessons from the dutch and danish biliary atresia registries
(
- Contribution to journal › Article
- 2007
-
Mark
Prevention of bleeding in haemophilia: trends, overcoming barriers and future treatment options
(
- Contribution to journal › Debate/Note/Editorial
- 2006
-
Mark
Compliance with treatment and understanding of own disease in patients with severe and moderate haemophilia
(
- Contribution to journal › Article
-
Mark
The von Willebrand Disease Prophylaxis Network (vWD PN): Exploring a treatment concept.
(
- Contribution to journal › Article
-
Mark
Practice patterns in haemophilia A therapy - global progress towards optimal care
(
- Contribution to journal › Article
-
Mark
Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3.
(
- Contribution to journal › Article
-
Mark
Acute Otitis Media. Aspects of diagnosis and prophylaxis
2006)(
- Thesis › Doctoral thesis (compilation)
- 2005
-
Mark
Changing pattern of care of boys with haemophilia in western European centres
(
- Contribution to journal › Article
- 2004
-
Mark
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients
(
- Contribution to journal › Article
-
Mark
Appropriate prophylaxis with restrictive palivizumab regimen in preterm children in Sweden
(
- Contribution to journal › Article
-
Mark
Optimizing factor prophylaxis for the haemophilia population: where do we stand?
(
- Contribution to journal › Article
- 2003
-
Mark
Pathogens in acute otitis media - impact of intermittent penicillin V prophylaxis on infant nasopharyngeal flora
(
- Contribution to journal › Article
- 2002
-
Mark
Use of folic acid and delivery outcome: a prospective registry study
(
- Contribution to journal › Article
-
Mark
Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients
(
- Contribution to journal › Article
-
Mark
Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen
(
- Contribution to journal › Article
- 2001
-
Mark
Symposium in memory of Professor Inga Marie Nilsson
(
- Contribution to journal › Published meeting abstract
- 2000
-
Mark
Treatment of children with haemophilia in Europe: A survey of 20 centres in 16 countries
(
- Contribution to journal › Article
- 1999
-
Mark
Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized
(
- Contribution to journal › Article
- 1998
-
Mark
The Malmo-Klaipeda WFH twinning programme: a comparative description of the haemophilia cohorts
(
- Contribution to journal › Scientific review
-
Mark
Multidose pharmacokinetics of factor IX: implications for dosing in prophylaxis
(
- Contribution to journal › Article
-
Mark
Prophylactic treatment in Sweden - Overtreatment or optimal model?
(
- Contribution to journal › Article
-
Mark
Can haemophilic arthropathy be prevented?
(
- Contribution to journal › Special issue (editor)
- 1997
-
Mark
Pharmacokinetic dosing of factor VIII and factor IX in prophylactic treatment of haemophilia
1997)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Improved cost-effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia A
(
- Contribution to journal › Article
- 1996
-
Mark
Hemophilia A and B with special reference to prevention and treatment of arthropathy
1996)(
- Thesis › Doctoral thesis (compilation)
- 1988
-
Mark
Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis
(
- Contribution to journal › Article